News
TEM
42.94
-2.76%
-1.22
Reiterating Buy: Tempus’s Underappreciated AI Data Advantage and Genomics Upside After a 50% Share Price Reset
TipRanks · 2h ago
Tempus AI upgraded to Buy from Hold at TD Securities
TipRanks · 2h ago
Weekly Report: what happened at TEM last week (0406-0410)?
Weekly Report · 2h ago
Tempus AI initiated with an Underperform at Jefferies
TipRanks · 12h ago
Does Tempus AI’s (TEM) Deeper Gilead Tie Mark a Shift in Its Platform Strategy?
Simply Wall St · 1d ago
William Blair health diagnostics analyst holds analyst/industry conference call
TipRanks · 2d ago
Gilead Expands Partnership With Tempus AI To Power Cancer Discoveries
Benzinga · 3d ago
Tempus AI Gilead Expansion Deepens Role In Oncology Drug Development
Simply Wall St · 3d ago
Amazon, Snowflake, Tempus AI, Arrive AI And Eos Energy: Why These 5 Stocks Are On Investors' Radars Today
Benzinga · 3d ago
Gilead Expands Tempus AI Partnership To Boost Oncology Pipeline
Benzinga · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Zscaler, Carlyle, Weight Watchers
Reuters · 3d ago
Tempus AI announce strategic collaboration with Gilead
TipRanks · 3d ago
Tempus AI Expands Collaboration With Gilead Sciences To Maximize Insights In Oncology Pipeline
NASDAQ · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Marvell Technology, Tempus AI, Energy Vault
Reuters · 3d ago
BUZZ-Tempus AI rises as it expands cancer research partnership with Gilead
Reuters · 3d ago
Tempus AI Announces Expanded, Multi-Year Collaboration With Gilead Sciences Aimed At Building And Advancing Gilead's Oncology Pipeline
Benzinga · 3d ago
TEMPUS ANNOUNCES STRATEGIC COLLABORATION WITH GILEAD TO ADVANCE ONCOLOGY R&D THROUGH RWE
Reuters · 3d ago
Tempus expands multi-year oncology RWE collaboration with Gilead Sciences
Reuters · 3d ago
Tempus AI CFO to speak at Needham Virtual Healthcare Conference
Reuters · 4d ago
Largest borrow rate increases among liquid names
TipRanks · 4d ago
More
Webull provides a variety of real-time TEM stock news. You can receive the latest news about Tempus AI through multiple platforms. This information may help you make smarter investment decisions.
About TEM
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.